Research for scientific breakthroughs that improve the treatment of asthma and COPD.
We research innovations that improve life with asthma and COPD
Our over 40 years of experience in the field of respiratory science is only the beginning of our story. The latest developments in the field of respiratory diseases mark the beginning of a new era of unprecedented potential to deliver scientific breakthroughs and change the lives of people with asthma and COPD (chronic obstructive pulmonary disease).
Our overall ambition is to modify respiratory disease and ultimately cure. We believe we can do that by addressing the underlying biological drivers of the disease. Advancements in biotechnology have expanded our toolkit of drug modalities. This provides an opportunity to design therapeutics for disease mechanisms previously considered difficult, if not impossible, to target and enables our scientists to pioneer new approaches to drug discovery.
Our focus on unmet medical needs
The global burden of respiratory disease
We raise awareness of the continuing unmet medical needs in asthma, COPD and idiopathic pulmonary fibrosis (IPF).
Inhalation therapies and novel combinations
We optimize our portfolio of inhalation drugs across the entire disease spectrum - for better choice and improved outcomes for patients.
Development of targeted biological therapies
We use new scientific insights into the biology of respiratory diseases and patient phenotypes to develop targeted biological therapies.
Innovation and commitment to improve patients’ health.
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.